Follow
Marta Ruiz Riol
Marta Ruiz Riol
Investigador Asociado, Instituto de Recerca de la Sida IrsiCaixa
Verified email at irsicaixa.es
Title
Cited by
Cited by
Year
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control
B Mothe, A Llano, J Ibarrondo, J Zamarreño, M Schiaulini, C Miranda, ...
PloS one 7 (1), e29717, 2012
1612012
Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers
M Rosás-Umbert, A Llano, R Bellido, A Olvera, M Ruiz-Riol, M Rocafort, ...
Journal of virology 93 (4), 2019
452019
Analysis of the cumulative changes in Graves’ disease thyroid glands points to IFN signature, plasmacytoid DCs and alternatively activated macrophages as chronicity determining …
M Ruiz-Riol, MPA Barnils, RC Oriol, AS Pla, FEB Serres, A Lucas-Martin, ...
Journal of autoimmunity 36 (3-4), 189-200, 2011
432011
Expression and function of the IL‐2 receptor in activated human plasmacytoid dendritic cells
M Naranjo‐Gómez, H Oliva, N Climent, MA Fernández, M Ruiz‐Riol, ...
European journal of immunology 37 (7), 1764-1772, 2007
432007
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
L Bailón, A Llano, S Cedeño, T Escribà, M Rosás-Umbert, M Parera, ...
Nature Medicine, 1-11, 2022
392022
Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control
B Oriol-Tordera, M Berdasco, A Llano, B Mothe, C Gálvez, ...
PLoS Pathogens 16 (8), e1008678, 2020
362020
In vivo effects of romidepsin on T-cell activation, apoptosis and function in the BCN02 HIV-1 kick&kill clinical trial
M Rosás-Umbert, M Ruiz-Riol, MA Fernández, M Marszalek, P Coll, ...
Frontiers in immunology 11, 418, 2020
322020
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
A Borgognone, M Noguera-Julian, B Oriol, L Noël-Romas, M Ruiz-Riol, ...
Microbiome 10 (1), 1-15, 2022
312022
Identification of interleukin-27 (IL-27)/IL-27 receptor subunit alpha as a critical immune axis for in vivo HIV control
M Ruiz-Riol, D Berdnik, A Llano, B Mothe, C Gálvez, S Pérez-Álvarez, ...
Journal of virology 91 (16), 2017
272017
Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected
M Ruiz-Riol, A Llano, J Ibarrondo, J Zamarreño, K Yusim, V Bach, ...
The Journal of infectious diseases 211 (6), 936-946, 2015
252015
Overexpression of metallothionein I/II: a new feature of thyroid follicular cells in Graves' disease
M Ruiz-Riol, MJ Martinez-Arconada, N Alonso, B Soldevila, D Marchena, ...
The Journal of Clinical Endocrinology & Metabolism 97 (2), 446-454, 2012
152012
TLR‐activated conventional DCs promote γ‐secretase‐mediated conditioning of plasmacytoid DCs
B Pérez‐Cabezas, M Naranjo‐Gómez, M Ruiz‐Riol, P Bastos‐Amador, ...
Journal of leukocyte biology 92 (1), 133-143, 2012
142012
Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells
M Kobayashi-Ishihara, KF Smutná, FE Alonso, J Argilaguet, ...
bioRxiv, 2022
122022
Detection of HIV-1-specific T-cell immune responses in highly HIV-exposed uninfected individuals by in-vitro dendritic cell co-culture
AC Guardo, M Ruiz-Riol, E Fernández, MJ Maleno, ME Bargalló, A Leon, ...
Aids 29 (11), 1309-1318, 2015
112015
Can we just kick-and-kill HIV: possible challenges posed by the epigenetically controlled interplay between HIV and host immunity
M Ruiz-Riol, C Brander
Immunotherapy 11 (11), 931-935, 2019
102019
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
B Oriol-Tordera, A Esteve-Codina, M Berdasco, M Rosás-Umbert, ...
EBioMedicine 78, 103956, 2022
92022
Benzyl-2-acetamido-2-deoxy-α-d-galactopyranoside increases human immunodeficiency virus replication and viral outgrowth efficacy in vitro
A Olvera, JP Martinez, M Casadellà, A Llano, M Rosás, B Mothe, ...
Frontiers in immunology 8, 2010, 2018
82018
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction
C Duran-Castells, A Llano, A Kawana-Tachikawa, A Prats, ...
Journal of Virology 97 (2), e01655-22, 2023
52023
Pharmacokinetic/pharmacodynamic analysis of romidepsin used as an HIV latency reversing agent
J Moltó, M Rosás-Umbert, C Miranda, C Manzardo, MC Puertas, ...
Journal of Antimicrobial Chemotherapy 76 (4), 1032-1040, 2021
52021
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation
IJ Ezeonwumelu, E García-Vidal, E Felip, MC Puertas, B Oriol-Tordera, ...
Frontiers in immunology, 5026, 2022
42022
The system can't perform the operation now. Try again later.
Articles 1–20